The future is here, and the Swan-Ganz is not in it.
Okay, so that headline may be a bit of an overstatement but this is something most of us figured would come some day:
From the ImaCor website:
ImaCor announces that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the ClariTEE™ probe and the Zura™ imaging system. The ClariTEE™ probe is a miniaturized transesophageal echocardiography probe which facilitates episodic monitoring of cardiac function. The ClariTEE™ is a single use device that can remain indwelling for up to 72 hours, allowing intensivists and anesthesiologists to periodically assess cardiac preload and left ventricular systolic function over a prolonged period of time.
The Swan-Ganz catheter has fallen out of favor in many circles for it’s complications and inaccuracies. This may be the substitute we’ve all been waiting for. Anyone know when the next TEE course is? You know the one in Waikiki?
